Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus.
about
Systemic antibiotic therapy for chronic osteomyelitis in adultsFactors predictive of treatment failure in staphylococcal prosthetic vascular graft infections: a prospective observational cohort study: impact of rifampin.Predisposing factors for recurrence of chronic posttraumatic osteomyelitis: a retrospective observational cohort study from a tertiary referral center in Brazil.Common changes in global gene expression induced by RNA polymerase inhibitors in Shigella flexneriStaphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.Improved outcome with early rifampicin combination treatment in methicillin-sensitive Staphylococcus aureus bacteraemia with a deep infection focus - a retrospective cohort studyOutcome of patients with streptococcal prosthetic joint infections with special reference to rifampicin combinations.Teicoplanin-based antimicrobial therapy in Staphylococcus aureus bone and joint infection: tolerance, efficacy and experience with subcutaneous administration.Outcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapySuccess after treatment of periprosthetic joint infection: a Delphi-based international multidisciplinary consensus.Prosthesis infections after orthopedic joint replacement: the possible role of bacterial biofilmsVancomycin-rifampin combination therapy has enhanced efficacy against an experimental Staphylococcus aureus prosthetic joint infection.Polymeric nanofiber coating with tunable combinatorial antibiotic delivery prevents biofilm-associated infection in vivoAntimicrobial-related severe adverse events during treatment of bone and joint infection due to methicillin-susceptible Staphylococcus aureus.Periprosthetic joint infection--effect on quality of lifeCurrent pharmacotherapy options for osteomyelitis: convergences, divergences and lessons to be drawn.Current concepts in the management of prosthetic joint infection.Staphylococcus aureus chronic and relapsing infections: Evidence of a role for persister cells: An investigation of persister cells, their formation and their role in S. aureus disease.A Retrospective Review of the Clinical Experience of Linezolid with or Without Rifampicin in Prosthetic Joint Infections Treated with Debridement and Implant Retention.An update on surgical and antimicrobial therapy for acute periprosthetic joint infection: new challenges for the present and the future.Is prosthesis retention effective for chronic infections in hip arthroplasties? A systematic literature review.Influence of daily dosage and frequency of administration of rifampicin-levofloxacin therapy on tolerance and effectiveness in 154 patients treated for prosthetic joint infections.Microbiological Diagnosis of Implant-Related Infections: Scientific Evidence and Cost/Benefit Analysis of Routine Antibiofilm Processing.Population pharmacokinetics of rifampicin in adult patients with osteoarticular infections: interaction with fusidic acid.Intracellular Pharmacokinetics of Antibacterials and Their Clinical Implications.New in vitro and in vivo models to evaluate antibiotic efficacy in Staphylococcus aureus prosthetic vascular graft infection.Bacteria antibiotic resistance: New challenges and opportunities for implant-associated orthopedic infections.Infection recurrence factors in one- and two-stage total knee prosthesis exchanges.Good quality of life outcomes after treatment of prosthetic joint infection with debridement and prosthesis retention.Antibacterial effect of antibiotic-loaded SBA-15 on biofilm formation by Staphylococcus aureus and Staphylococcus epidermidis.Importance of selection and duration of antibiotic regimen in prosthetic joint infections treated with debridement and implant retention.Prosthetic knee infection by resistant bacteria: the worst-case scenario.Efficacy of Single-stage Revision with Aggressive Debridement Using Intra-articular Antibiotics in the Treatment of Infected Joint Prosthesis.Predictors of treatment outcome in prosthetic joint infections treated with prosthesis retention.Effectiveness of gentamicin-containing collagen sponges for prevention of surgical site infection after hip arthroplasty: a multicenter randomized trial.Which method is the most effective for preventing postoperative infection in spinal surgery?Pharmacokinetic variability of clindamycin and influence of rifampicin on clindamycin concentration in patients with bone and joint infections.Oral antibiotic therapy.Irrigation and debridement.Etiology of surgical site infections after primary total joint arthroplasties.
P2860
Q28714211-5ECA9BA7-CA6B-4180-B485-0E928CC57D31Q33726771-ABDCB72A-BA87-4B3F-912C-E78D24B1C632Q33759244-21002153-4C15-49B6-B1AF-E9827E7060B8Q34200649-CF0F7DB2-C000-49D6-9614-6FF18A5C533AQ34478074-CC066FE6-EB25-4F1D-8A9E-D91D6348FCA3Q35391386-FF26EFB9-3263-4722-B52A-F82C64143445Q36163096-C1F102B6-5734-454D-9EC7-E78B657F3964Q36181397-0EC4F835-7A30-4BD6-B682-1A0E39FA90C9Q36505327-B4ADCCCD-3C91-4C34-8A5B-1BED10F81D09Q36912994-408A7453-F591-4839-9F9F-9768B4F2BFDBQ37032050-907CF620-CE22-4CDF-801B-1F6CF331DAE1Q37263918-4930559C-92FE-4B93-A0D6-1B31AA8DD63BQ37417976-F63EC011-97DA-4A9B-9B0F-D534AB746E82Q37544629-322A85BF-F4C2-4FDE-9458-E48B64E91197Q37720136-E377A115-E4C3-4C5B-B8D7-EDC83D11318DQ38089918-0A39A907-9A32-43D7-905A-662D20D739C6Q38221335-47BC5A4C-EEE9-4F03-AB3C-AD4F0D6F6B55Q38237595-CECBF163-215D-4110-AD69-CB489982B8B0Q38241474-F3B1CF4C-7A50-4BCC-939E-E790BC5C249DQ38314400-D3412834-A558-42A3-B450-B7E1192508FDQ38450497-181B91E9-9D28-40F8-AE89-D7037F420AD9Q38490164-2B8B7594-6906-4415-AFD9-24EB9E5A08B7Q38999377-253EE2C0-1056-4A56-A1EA-4DC10FCA3639Q39215691-9386CCF2-E7DC-4197-9D30-4B994FF1A10EQ39390126-79380408-E953-4349-8A26-741891E2E4F4Q40018152-97F7205C-DE40-4311-B5E7-344BB7976E15Q40128761-94873F54-2350-406A-B789-ED2BBAB6790CQ40269668-255F6D46-7B92-4112-9B2B-88E691EFA9F9Q40374830-BD186FF2-CF98-408F-90B9-AE938ED1A2ECQ40401375-428F1768-16C2-47FC-A67C-FA641536C528Q40772358-E288F883-E939-49F0-BB2F-2EFCFC304820Q40810078-63C37495-4966-4552-8E97-AA0313422F5FQ41049090-27758507-0632-4CFE-974A-BD6F20A4B87AQ41126065-EBA8D957-3E34-468F-9247-6C0BFBC085B9Q41303083-6F7AFC00-1041-4285-BC3C-12529E4F2E5AQ41308062-2B944680-E639-4481-B1D4-8B02024CDF26Q41359629-F23A2F5E-A333-4947-8F53-25DE66B2AB04Q42231206-9D2A84C6-4FE4-4F52-8C50-EC01003EF913Q42231216-6C67AF45-EBA5-4309-829E-9224BFEAFBC6Q42232531-CFA8EBB2-D2D6-4DAA-B725-9F8D2F5B1DC3
P2860
Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus.
description
2011 nî lūn-bûn
@nan
2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Outcome and predictors of trea ...... due to Staphylococcus aureus.
@ast
Outcome and predictors of trea ...... due to Staphylococcus aureus.
@en
type
label
Outcome and predictors of trea ...... due to Staphylococcus aureus.
@ast
Outcome and predictors of trea ...... due to Staphylococcus aureus.
@en
prefLabel
Outcome and predictors of trea ...... due to Staphylococcus aureus.
@ast
Outcome and predictors of trea ...... due to Staphylococcus aureus.
@en
P2093
P2860
P356
P1476
Outcome and predictors of trea ...... due to Staphylococcus aureus.
@en
P2093
Bernadette Roselé
Carlos Maynou
Caroline Loïez
Donatienne Joulie
Eric Beltrand
Eric Senneville
Henri Migaud
Hervé Dezèque
Laurence Legout
Michel Valette
P2860
P304
P356
10.1093/CID/CIR402
P407
P577
2011-08-01T00:00:00Z